| Size | Price | Stock |
|---|---|---|
| 1g | $5 | In-stock |
| 5g | $15 | In-stock |
| 25g | $28 | In-stock |
| 100g | $77 | In-stock |
| 500g | $307 | In-stock |
| 1 kg | Get quote | |
| 2 kg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-42680 |
| M.Wt: | 180.16 |
| Formula: | C6H12O6 |
| Purity: | >98 % |
| Solubility: | DMSO : 100 mg/mL (ultrasonic;warming;heat to 60°C) |
D-Tagatose (D-(-)-Tagatose) is a natural low-calorie rare sugar. D-Tagatose inhibits the activities of sucrase, maltase and intestinal disaccharidases, reduces the digestion of sucrose and starch, and blocks the absorption of sucrose, maltose and glucose. D-Tagatose promotes glucokinase activity and inhibits glycogen phosphorylase activity via tagatose-1-phosphate, regulates the synthesis and decomposition of hepatic glycogen, reduces postprandial and fasting blood glucose levels, and improves hyperinsulinemia. D-Tagatose regulates lipid profiles, stimulates GLP-1 secretion, and exhibits prebiotic effects. D-Tagatose is a bulking sweetener. D-Tagatose can be used in research related to diabetes, hyperlipidemia, dental caries, atherosclerosis and type 2 diabetes[1][2][3].
In Vitro:D-Tagatose was synthesized from starch via an ATP-free in vitro multi-enzyme pathway, with high yield enabled by the final irreversible dephosphorylation step[1].
D-Tagatose does not increase mutation frequency in mouse L5178Y lymphoma cancer cells, with or without metabolic activation[2].
D-Tagatose is thermally stable in milk and lemonade, with minimal degradation and preserved prebiotic activity during processing and storage[2].
In Vivo:D-Tagatose (4000-20000 mg/kg/day; i.g.; daily; gestational days 6 to 15) shows no developmental toxicity in Sprague-Dawley rats at doses up to 20000 mg/kg/day, with only transient gastrointestinal effects and reduced food intake at mid and high doses[2].
D-Tagatose (sole carbohydrate source in diet; dietary; ad libitum; 16 weeks), when substituted for sucrose in hypercholesterolemic mouse diets, prevents the development of obesity, hyperglycemia, hyperlipidemia, and atherosclerosis observed with sucrose feeding[2].
D-Tagatose produces antidiabetic effects in the SHR/N-cp rat model of type 2 diabetes[2].
D-Tagatose (0.9-1.8 g/(rat·d); oral; mixed with basal diet; 21-day adaptation period; 40-41-day balance period) provides effectively zero net metabolizable energy to growing male Wistar rats, with a calculated NEVs of -0.5 kJ/g that is not significantly different from zero[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.